Advertisement
Canada markets open in 8 hours 1 minute

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7326
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     

  • Bitcoin CAD

    87,627.89
    +196.04 (+0.22%)
     

  • CMC Crypto 200

    1,385.64
    +3.07 (+0.22%)
     

  • GOLD FUTURES

    2,349.30
    +6.80 (+0.29%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,765.25
    +197.75 (+1.13%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    38,048.94
    +420.46 (+1.12%)
     

  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

PI Financial Cuts Aurora Cannabis’s Price Target

Adam Jones
Updated
PI Financial Cuts Aurora Cannabis’s Price Target

On May 14, Aurora Cannabis (ACB) (ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars in one of the biggest deals in the cannabis sector (MJ). Following the news, MedReleaf stock was heavily traded with a volume of 3.3 million shares and closed at 25.3 Canadian dollars. Read MedReleaf Stock Rises on Aurora Cannabis Acquisition to learn more. Similar to Canopy Growth (WEED), the mean ratings for Aurora Cannabis also improved from 2.3 a month ago in April, which indicates that analysts were more bullish on the stock month-over-month.

Continue reading